Tags: Drug.

Dasatinib previously known as BMS-354825 is a cancer drug produced by Bristol-Myers Squibb and sold under the trade name Sprycel. Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers including advanced prostate cancer.

Dasatinib2DACS2.svg
ATC prefix
L01
ATC suffix
XE06
CAS number
302962-49-8
ChEBI
49375
DrugBank
DB01254
FDA UNII code
X78UG0A0RN
IUPAC name
N-(2-chloro-6-methylphenyl)-2-6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide monohydrate
PubChem
3062316

Loading...

This page contains content from the copyrighted Wikipedia article "Dasatinib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.